San-Chi Chen

7PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 21, 2026
Optimizing Systemic Therapy for Advanced Sarcomas: Outcomes With Gemcitabine, Docetaxel, Cisplatin, and Everolimus in a Retrospective Single-Center Study.

|Oct 20, 2025
Complete Remission of Hepatocellular Carcinoma With Atezolizumab and Bevacizumab Following Prior B-cell Depletion.

Jen-Pei Huang, Chun-Kuang Tsai, Pei-Ying Hsieh

|Nov 23, 2024
Efficacy and safety of durvalumab rechallenge in advanced hepatocellular carcinoma patients refractory to prior anti-PD-1 therapy.

Kuan-Chang Lai, Yen-Hao Chen, Yi-Ping Hung

|Oct 01, 2022
Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: A case report.

Yi-Hsuan Lai, Kai-Che Tung, San-Chi Chen

|Sep 21, 2022
A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma.

Tom Wei-Wu Chen, Chia-Lang Hsu, Ruey-Long Hong

|Jul 18, 2022
Impaired Chromatin Remodeling Predicts Better Survival to Modified Gemcitabine and S-1 plus Nivolumab in Advanced Biliary Tract Cancer: A Phase II T1219 Study.

Nai-Jung Chiang, Kien Thiam Tan, Li-Yuan Bai

Pageof 2

Frequent Collaborators

1 joint publications

Nai-Jung Chiang

1 joint publications

Kien Thiam Tan

1 joint publications

Li-Yuan Bai

1 joint publications

Chin-Fu Hsiao